• 1
    CurtisRE,FreedmanDM,RonE, et al., editors. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973–2000. NIH Pub. No. 05-5302. Bethesda, MD: National Cancer Institute; 2006.
  • 2
    Ahsan H,Neugut AI. Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med. 1998; 128: 114117.
  • 3
    Rheingold SR,Neugut AI,Meadows AT. Secondary cancers: incidence, risk factors, and management. In: KufeDW,PollockRE,WeichselbaumRR, et al., editors. Cancer Medicine.6th ed. Hamilton, Ontario, Canada: BC Decker; 2003: 26232631.
  • 4
    Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev. 2006; 15: 20202026.
  • 5
    Andersen BL,Shapiro CL,Farrar WB,Crespin T,Wells-Digregorio S. Psychological responses to cancer recurrence. Cancer. 2005; 104: 15401547.
  • 6
    Munkres A,Oberst MT,Hughes SH. Appraisal of illness, symptom distress, self-care burden, and mood states in patients receiving chemotherapy for initial and recurrent cancer. Oncol Nurs Forum. 1992; 19: 12011209.
  • 7
    Oh S,Heflin L,Meyerowitz BE,Desmond KA,Rowland JH,Ganz PA. Quality of life of breast cancer survivors after a recurrence: a follow-up study. Breast Cancer Res Treat. 2004; 87: 4557.
  • 8
    Ganz PA,Goodwin PJ. Quality of life in breast cancer: what have we learned and where do we go from here? In: LipscombJ,GotayCC,SnyderC, editors. Outcomes Assessment in Cancer: Measures, Methods and Applications. Cambridge, U.K.: Cambridge University Press; 2005: 93125.
  • 9
    Scheier MF,Carver CS. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol. 1985; 4: 219247.
  • 10
    Wagnild GM,Young HM. Development and psychometric evaluation of the Resilience Scale. J Nurs Meas. 1993; 1: 165178.
  • 11
    Carver CS,Pozo C,Harris SD, et al. How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol. 1993; 65: 375390.
  • 12
    Gotay CC,Isaacs P,Pagano I. Quality of life in patients who survive a dire prognosis compared to control cancer survivors. Psychooncology. 2004; 13: 882892.
  • 13
    Charlson ME,Pompei P,Ales KL,MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373383.
  • 14
    Aaronson NK,Ahmedzai S,Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365376.
  • 15
    Bernhard J,Sullivan M,Hurny C,Coates AS,Rudenstam CM. Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer. 2001; 84: 11561165.
  • 16
    de Boer AG,van Lanschot JJ,Stalmeier PF, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res. 2004; 13: 311320.
  • 17
    Ware JEJr,Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473483.
  • 18
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1977; 1: 385401.
  • 19
    Beeber LS,Shea J,McCorkle R. The Center for Epidemiologic Studies Depression Scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol. 1998; 16: 120.
  • 20
    Hann D,Winter K,Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999; 46: 437443.
  • 21
    Weiss D,Marmar C. The Impact of Events Scale-Revised. In: WilsonJ,KeaneT, editors. Assessing Psychological Trauma and PTSD. New York: Guildford; 1997: 399411.
  • 22
    Tedeschi RG,Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996; 9: 455471.
  • 23
    Widows MR,Jacobsen PB,Booth-Jones M,Fields KK. Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol. 2005; 24: 266273.
  • 24
    Waterhouse J,Metcalfe MC. Development of the sexual adjustment questionnaire. Oncol Nurs Forum. 1986; 13: 5359.
  • 25
    Cohen SR,Mount BM,Tomas JJ,Mount LF. Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire. Cancer. 1996; 77: 576586.
  • 26
    Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000; 36: 453471.
  • 27
    Cohen J. Statistical Power Analysis for the Behavioral Sciences ( 2nd ed.). Hillsdale, NJ: Erlbaum; 1988.
  • 28
    Antoni MH,Lehman JM,Kilbourn KM, et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001; 20: 2032.
  • 29
    Aarstad HJ,Aarstad AK,Birkhaug EJ,Bru E,Olofsson J. The personality and quality of life in HNSCC patients following treatment. Eur J Cancer. 2003; 39: 18521860.
  • 30
    Ransom S,Jacobsen PB,Schmidt JE,Andrykowski MA. Relationship of problem-focused coping strategies to changes in quality of life following treatment for early stage breast cancer. J Pain Symptom Manage. 2005; 30: 243253.
  • 31
    Alfano CM,Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006; 12: 432443.
  • 32
    Arndt V,Stegmaier C,Ziegler H,Brenner H. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer. 2006; 107: 24962503.
  • 33
    Gotay CC,Moinpour CM,Unger JM, et al. Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol. 2007; 25: 20932099.
  • 34
    Pakilit AT,Kahn BA,Petersen L,Abraham LS,Greendale GA,Ganz PA. Making effective use of tumor registries for cancer survivorship research. Cancer. 2001; 92: 13051314.
  • 35
    Potosky AL,Knopf K,Clegg LX, et al. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001; 19: 37503757.
  • 36
    Ramsey SD,Andersen MR,Etzioni R, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000; 88: 12941303.